EdU Flow Cytometry Assay Kits (Cy3)
Measuring cell proliferation and cell cycle are a fundamental method to assess cell health, determine genotoxicity, and evaluate drug’s pharmacodynamic effect. The common method is measuring DNA synthesis directly. In previous experiments, there are several approaches such as the incorporation of radioactive nucleosides (3H-thymidine) or BrdU. Here, we introduce one new method, click chemistry-CuAAC (Copper-Catalyzed Azide-Alkyne Cycloaddition), and the use of this reaction in direct measurement of S-phase DNA synthesis in cell cycle.
A nucleoside analog of thymidine, EdU (5-ethynyl-2’-deoxyuridine), can be incorporated into DNA strand during DNA synthesis. The alkynyl group of EdU is a biologically inert group that will undergo an extremely selective reaction with dye’s azido via a CuAAC reaction to afford an 1,2,3-triazole product. EdU and Cy3 azide possess biologically unique moieties to label DNA of proliferating cells, producing low backgrounds and high detection sensitivities. This CuAAC reaction affords superior regioselectivity and quantitative transformation under extremely mild conditions.
EdU Flow Cytometry Assay Kits (Cy3) is a sensitive and reliable way to detect and quantify cell proliferation in cells. It is optimized for flow cytometry.

- 1. Zhijin Zhang, Wentao Zhang, et al. "Immunosuppressive role of benzo [a] pyrene exposure in prostate cancer progression." Journal of Environmental Sciences Volume 156, October 2025, Pages 185-199. PMID: 40412924
- 2. Hongyan Li, Yi Liu, Xianbao Shi. "SP1/ADAM10/DRP1 axis links intercellular communication between smooth muscle cells and endothelial cells under hypoxia pulmonary hypertension." Biochim Biophys Acta Mol Basis Dis. 2025 Apr;1871(4):167720. PMID: 39956207
- 3. Jingcheng Zhang, Wentao Zhang, et al. "SOX7 inhibits the malignant progression of bladder cancer via the DNMT3B/CYGB axis." Mol Biomed. 2024 Sep 4;5(1):36. PMID: 39227479
- 4. Zheng Yin, Jishou Zhang, et al. "EDIL3/Del-1 prevents aortic dissection through enhancing internalization and degradation of apoptotic vascular smooth muscle cells." Autophagy. 2024 Jul 1:1-21. PMID: 38873925
- 5. Yue Huang, Dapeng Chen, et al. "ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation." BMC Cancer. 2024 Apr 11;24(1):452. PMID: 38605349
- 6. Yiqing Sun, Kaiwen Zhang, et al. "A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma." Sci Rep. 2024 Mar 13;14(1):6134. PMID: 38480789
- 7. Shengrong Sun, et al. "Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway." Sci Rep. 2024 Feb 27;14(1):4732. PMID: 38413708
- 8. Pengping Li, Shaowen Wang, et al. "Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion." Front Immunol. 2024 Jan 26:15:1258475. PMID: 38352883
- 9. Liu Chaojun, Li Pengping, et al. "TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification." Aging (Albany NY). 2023 Nov 10;15(22):12890-12906. PMID: 37950731
- 10. Xian Lin, Jian Chen, et al. "Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease." MedComm (2020). 2023 Feb 22;4(2):e219. PMID: 36845072
Related Biological Data

Related Biological Data

| Components | K1077-100 Test |
| EdU (Component A) | 20 mg |
| Cy3 Azide (Component B) | 1 vial |
| DMSO (Component C) | 8.5 mL |
| CuSO4 (100 mM Aqueous Solution) (Component D) | 1 mL |
| EdU Buffer Additive (Component E) | 400 mg |
Store the kit at -20ºC away from light and moisture, stable for 1 year. | |
Simple works in less time with no denaturation steps or harsh treatment
High efficiency with robust brightness
Compatible with some antibodies and cell cycle dyes
High consistency because of independence of variable anti-BrdU antibody












